FREQUENT EXCHANGE OF PLASTIC STENTS COULD AFFECT THE PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED EXTRAHEPATIC CHOLANGIOCARCIONMA RECEIVING NAB- PACLITAXEL PLUS GEMCITABINE-CISPLATIN

Min Je Sung: NO financial relationship with a commercial interest | Chang-Il Kwon: NO financial relationship with a commercial interest | Jaekyung Cheon: NO financial relationship with a commercial interest | Beodeul Kang: NO financial relationship with a commercial interest | Hong Jae Chon: YES financial relationship with a commercial interest;Eisai:Advisory Committees or Review Panels;Roche:Advisory Committees or Review Panels;Bayer:Advisory Committees or Review Panels;ONO:Advisory Committees or Review Panels;MSD:Advisory Committees or Review Panels;BMS:Advisory Committees or Review Panels;Celgene:Advisory Committees or Review Panels;Sanofi:Advisory Committees or Review Panels;Servier:Advisory Committees or Review Panels;AstraZeneca:Advisory Committees or Review Panels;Sillajen:Advisory Committees or Review Panels;Menerini:Advisory Committees or Review Panels;Dong-A ST:Grant/Research Support;Roche:Grant/Research Support | Incheon Kang: NO financial relationship with a commercial interest | Sung Hwan Lee: NO financial relationship with a commercial interest | Seok Jeong Yang: NO financial relationship with a commercial interest | Sung Hoon Choi: NO financial relationship with a commercial interest | Kwang Hyun Ko: NO financial relationship with a commercial interest